Navigation Links
Research Sheds Lights on Therapeutic Effect of Targeted Treatment of Localized Prostate Cancer
Date:4/15/2017

The effectiveness of the targeted therapy in the tumor treatment has now been ascertained by the research conducted by Dr. Song in his clinic.

The current research also sheds some light on Dr. Song’s 3D Prostate Targeted Treatment, which has emerged as a treatment to treat prostate diseases, including early-stage prostate cancer. The treatment is based on the traditional Chinese medicine drug compatibility, which can not only effectively remove cancerous tissues, but also can regulate the immune functions of a cancer patient. In this treatment, Dr. Song enhances the resistance to tumor cell damage through drug regulation. He focuses on to meet the individual needs of patients and administers his herbal drugs accordingly.

Dr. Xinping Song bases his treatment on the traditional Chinese medicine compatibility. He endeavors to achieve the treatment results in a natural manner without a need of doing a surgery or chemotherapy. The Chinese medicine compatibility also helps in the differentiation of different tumor cells and avoids direct strangulation of patients. The use of traditional herbal drugs can also reverse the deteriorating condition of a cancer patient who was subjected to multiple drugs of the western medicine system.

At Dr. Song 3D Urology and Prostate Clinic, a patient can witness positive results and an improvement in his prostate health because of the drug administered as per the traditional Chinese medicine compatibility. The drug helps in the decomposition of tumor cells and ensures a progressive drug inhibition intervention. Dr. Song’s 3D targeted treatment helps removing the cancerous cells, pathogens and calcification for patients to get the relief from the problem. To know more about Dr. Song’s treatment, one can visit the website http://www.prostatecancer.vip/.

About 3D Urology and Prostate Clinic

The 3D Urology and Prostate Clinic is a premier prostate treatment clinic. The clinic specializes in treating various types of prostate diseases and complications, such as prostatitis, enlarged prostate, benign prostatic hyperlasia (BPH), prostate cancer, seminal vesiculitis, epididymitis, cystitis, prostate blockage and calcification, and chronic pelvic pain syndrome (CPPS), etc. The clinic is a medical clinic, licensed and approved by the Ministry of Health of the People’s Republic of China.

For Media Enquiry –
Contact Person: Alisa Wang
Telephone: 86-186-7321-6429
WhatsApp: + 86 -186-73216429
Email: prostatecure3d(at)gmail(dot)com
Website: https://www.prostatecancer.vip/

Read the full story at http://www.prweb.com/releases/Dr-Song/3D-Targeted-Treatment/prweb14247465.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. NYC Injury Lawyers Block O'Toole & Murphy Hosted Their 2013 Autumn Wine Tasting Event To Benefit St. Jude Children's Research Hospital And It Was A Huge Success
2. UT Southwestern researchers discover a new driver of breast cancer
3. Dartmouth researcher finds novel genetic patterns that make us rethink biology and individuality
4. Lip Balm for Chapped Lips Often Incorrectly Applied Reports Water and Health Researcher
5. Global In Vitro Fertilization Market 2012-2016 New Research Report at ReportsnReports.com
6. Researchers at Pace University Explore the Lived Experiences of Families Members That Have the Possible Risk of Genetic Mutations That Cause Sudden Cardiac Death
7. BCC Research Publishes a New Report on Global Markets for Influenza Products
8. Penn Medicine receives award from Patient-Centered Outcomes Research Institute
9. Researchers identify a histone demethylase associated with non-small cell lung cancer
10. Global Blood Collection Systems Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2016
11. Lean On Life Supports New Research That Reveals Common Personality Traits Contributing to Weight Gain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... KICKICO ... a whitepaper that pledges to solve many catastrophic issues within funding campaigns. KICKICO ... , The typical notion of crowdfunding - the raising of funds through the power ...
(Date:6/25/2017)... , ... June 24, 2017 , ... Create a feel-good lyric music video in Final ... and sound in the timeline and write in the lyrics to any song. ProLyric flies ... out. Each line of the text can be added modularly for optimal control. ProLyric makes ...
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017 The Bio Supply Management Alliance (BSMA) ... Fremont and the Biomedical Manufacturing Network to ... California by providing a platform ... fostering workforce development. The primary focus of this alliance ... as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: